Trial Profile

Single Nuclei RNA-sequencing to Map Adipose Cellular Populations and Senescent Cells in Older Subjects

Status: Recruiting

Phase of Trial: Phase II/III

Latest Information Update: 26 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dasatinib (Primary) ; Quercetin (Primary)
Indications Obesity
Focus Therapeutic Use

Most Recent Events

12 Jan 2024 Status changed from not yet recruiting to recruiting.
14 Sep 2023 Phase of te study is changed from phase 0 to phase 1/2, study design changed from single-blind to double-blind, planned enrollment is increased and upper age limit of the inclusion criteria is increased from 16 to 18 years.
14 Sep 2023 Planned number of patients changed from 120 to 160.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com